Balyasny Asset Management
IPSC icon

Balyasny Asset Management’s Century Therapeutics IPSC Stock Holding History

Balyasny Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Buy
+5,017,733
New +$10.6M 0.01% 979

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management's IPSC Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Century Therapeutics (IPSC) in Q1 2026: 5,017,733 shares worth $11.3M. The stake represents 0.01% of the portfolio and ranks #979 among its holdings.

72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Balyasny Asset Management held 5,017,733 shares of Century Therapeutics worth $11.3M as of Q1 2026.
  • Century Therapeutics was a new Balyasny Asset Management position in Q1 2026.
  • Century Therapeutics made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #979 holding.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.